elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26750670-A22A39F3-1CA6-47DE-9913-60D02F1D42C1
Q26750670-A22A39F3-1CA6-47DE-9913-60D02F1D42C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750670-A22A39F3-1CA6-47DE-9913-60D02F1D42C1
Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review
P2860
Q26750670-A22A39F3-1CA6-47DE-9913-60D02F1D42C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26750670-A22A39F3-1CA6-47DE-9913-60D02F1D42C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60e946cb05a3ef53da765c98cc461abd615497b0
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer